SOX9 and neoplasm: We show that Sox9 is overexpressed within the lung ADC subgroup that harbors KRAS mutations, and confirm that Sox9 is overexpressed within the more malignant portions of tumor from the LSL-K-rasG12D lung ADC mouse model [9].